Fan Zhang, Zi-Yang Shi, Qing Shi, Yan Zhu, Wei Li Zhao, Li Wang. "A prospective, multicenter, randomized, controlled clinical trial comparing polatuzumab vedotin, zanubrutinib, lenalidomide, and rituximab (Pola-ZR2) versus zanubrutinib, lenalidomide, and rituximab (ZR2) in the treatment of previously untreated, elderly patients with diffuse large B-cell lymphoma (NCT06522555)." Blood (2025). https://doi.org/10.1182/blood-2025-3696